Mild cognitive impairment: Clinical features and review of screening instruments

Aging Clinical and Experimental Research

Volumn 13, Issue 3, 2001, Pages 183-202

  Galluzzi, S ^a   Cimaschi, L ^a   Ferrucci, L ^b   Frisoni, G B ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b INRCA   (Italy)

Author keywords

Alzheimer's disease; Cognitive screening tests; Dementia; Frailty; Mild cognitive impairment

Indexed keywords

ALPHA TOCOPHEROL; CHOLINESTERASE INHIBITOR; DONEPEZIL; PLACEBO;

AGED; ALZHEIMER DISEASE; CLINICAL FEATURE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEATH; DEMENTIA; DISEASE COURSE; EUROPE; FUNCTIONAL DISEASE; GENERAL PRACTICE; HUMAN; INSTITUTIONALIZATION; MEMORY CONSOLIDATION; MENTAL DETERIORATION; MENTAL TEST; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; NURSING HOME; PHYSICAL DISABILITY; PREVALENCE; RATING SCALE; REHABILITATION CENTER; REVIEW; RISK ASSESSMENT; SCREENING TEST; TREATMENT OUTCOME;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; DEMENTIA; DEMENTIA, VASCULAR; HUMANS; PSYCHOLOGICAL TESTS;

EID: 0034952343     PISSN: 03949532     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03351477     Document Type: Review

References (115)

1. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
2. Age-associated memory impairment: Proposed diagnostic criteria and measures of clinical change - Report of a national institute of mental health work group
3. Mild neurocognitive disorder: Needed addition to the nosology of cognitive impairment (organic mental) disorders
4. Criteria for diagnosing age associated memory impairment: Proposed improvements from the field
5. Aging-associated cognitive decline
6. Mild Cognitive Impairment - Clinical characterization and outcome
7. The Clinical Dementia Rating (CDR): Current version and scoring rules
8. Vitamin E and Alzheimer disease: The basis for additional clinical trials
9. Le demenze: Epidemiologia e fattori di rischio
10. Vascular dementia
11. Prevalence and outcomes of vascular cognitive impairment
12. The diagnosis of "mixed" dementia in the Consortium for the Investigation of Vascular Impairment of Cognition (CIVIC)
13. History of the concept of vascular dementia: Two opposing views on current definitions and criteria for vascular dementia
14. Vascular dementia: Diagnostic criteria for research studies
15. Neuropathological assessment of the lesions of significance in vascular dementia
16. The prevalence of white-matter lesions on computed tomography of the brain in demented and nondemented 85-year olds
17. A historical review of the concept of vascular dementia: Lessons from the past for the future
18. Vascular dementia: The role of cerebral infarcts
19. Conceptual background to vascular cognitive impairment
20. Rethinking vascular dementia
21. Research criteria for subcortical vascular dementia in clinical trials
22. Limitations of clinical criteria for the diagnosis of vascular dementia in clinical trials. Is a focus on subcortical vascular dementia a solution?
23. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial
24. A white matter disorder in dementia of the Alzheimer type: A pathoanatomical study
25. Diffuse white-matter disease in the geriatric population. A clinical, neuropathological, and CT study
26. Epidemiology of vascular dementia
27. Prevalence and incidence of dementia in Denmark
28. Dementing disorders in north Italy: Prevalence study in Vescovato, Cremona Province
29. Prevalence of dementia in an elderly rural population: Effects of age, sex, and education
30. Prevalence of Alzheimer's disease and vascular dementia: Association with education, the Rotterdam study
31. Prevalence of Alzheimer's disease and other dementing disorders in Pamplona, Spain
32. The prevalence of dementia and depression in the elderly community in a Southern European population: The Zaragoza study
33. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohort
34. Prevalence and outcomes of vascular cognitive impairment
35. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia aging study
36. Prevalence of dementia and its subtypes in the Japanese American population of King County, Washington State
37. A population-based study on the incidence of dementia disorders between 85 and 88 years of age
38. Undifferentiated dementia. Alzheimer's disease and vascular dementia: Age- and gender-related incidence in Liverpool: The MRC-ALPHA study
39. Incidence of clinically diagnosed subtypes of dementia in an elderly population. Cambridge project for later life
40. Incidence of dementia and major subtypes in Europe: A collaborative study of population-based study
41. Cardiovascular risk factors and cognitive decline in middle-aged adults
42. Frailty and the older man
43. Serum albumin level and physical disability as predictors of mortality in older persons
44. Screening for frailty: Criteria and predictors of outcomes
45. The relation between psychometric test performance and physical performance in older adults
46. Comorbidity and drug use in cognitively impaired elderly living in long-term care
47. Factors associated with institutionalisation of older people in Canada: Testing a multifactorial definition of frailty
48. Evaluating dementia screening tests. Methodologic standards to rate their performance
49. Documentation and evaluation of cognitive impairment in elderly primary care patients
50. II decadimento cognitivo lieve di origine degenerativa e vascolare
51. Impact of mild cognitive impairment on survival in very elderly people: Cohort study
52. Mortality in nondemented subjects with cognitive impairment: The influence of health-related factors
53. The natural history of non-demented cognitively impaired subjects: Population data from the Kungsholmen Project
54. A low, 'normal' score on the Mini-Mental State Examination predicts development of dementia after three years
55. Mild cognitive impairment in the population and physical health: Data on 1,435 individuals aged 75 to 95
56. Stability of age-associated memory impairment during a longitudinal population-based study
57. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
58. Delirium in clinical practice: Experiences from a specialized delirium ward
59. The risk of dementia and death after delirium
60. The prognostic significance of delirium in older hospital patients
61. Cognitive status at admission: Does it affect the rehabilitation outcome of elderly patients with hip fracture?
62. Factors related to length of stay in a Geriatric Evaluation and Rehabilitation Unit
63. Cognitive impairment and depression predict mortality in medically ill older adults
64. Effects of cognitive impairment on the reliability of geriatric assessments in nursing homes
65. Comorbidity and drug use in cognitively impaired elderly living in long-term care
66. Does the Clock Drawing Test predict cognitive decline in older persons independent of the Mini-Mental State Examination?
67. Brain structural and cognitive correlates of clock drawing performance in Alzheimer's disease
68. Clock-drawing: Is it the ideal cognitive screening test?
69. Clock-drawing and dementia in the community; a longitudinal study
70. A simple model for predicting postoperative delirium in older patients undergoing elective orthopaedic surgery
71. Factors affecting the results of the clock drawing test in elderly patients hospitalised for physical rehabilitation
72. Early identification of dementia: Predictive validity of the clock test
73. Use of the clock drawing task in the diagnosis of mild and very mild Alzheimer's disease
74. "Mini-mental State". A practical method for grading the cognitive state of patients for the clinician
75. The Mini-Mental State Examination: A comprehensive review
76. Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders
77. Predictors of recovery in activities of daily living among disabled older persons living in the community
78. Validation of a short Orientation-Memory-Concentration Test of cognitive impairment
79. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects
80. Equivalence of two screens of cognitive functioning: The Short Portable Mental Status Questionnaire and the Orientation-Memory-Concentration test
81. Comparison of two cognitive bedside screening instruments in nursing home residents: A factor analytic study
82. Validation of a 6 item cognitive impairment test with a view to primary care usage
83. Depression, intellectual impairment, and Parkinson disease
84. The Mini-Mental State Examination in the early diagnosis of Alzheimer's disease
85. The Modified Mini-Mental State (3MS) Examination
86. Community screening for dementia: The Mini Mental State Exam (MMSE) and Modified Mini Mental State Exam (3MS) compared
87. Mental status testing in the elderly nursing home population
88. Folstein vs Modified Mini-Mental State Examination in geriatric stroke. Stability, validity, and screening utility
89. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium
90. Validity of the Confusion Assessment Method in detecting postoperative delirium in the elderly
91. MDS Cognitive Performance Scale
92. Designing the national resident assessment instrument for nursing homes
93. Validation of the Minimum Data Set Cognitive Performance Scale: Agreement with the Mini-Mental State Examination
94. Validity and responsiveness of the Minimum Data Set
95. Screening for dementia with the Memory Impairment Screen
96. Aging encoding specificity, and memory change in the Double Memory Test
97. Screening for dementia by memory testing
98. Memory impairment on free and cued selective reminding predicts dementia
99. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia
100. CAMCOG - A concise neuropsychological test to assist dementia diagnosis: Socio-demographic determinants in an elderly population sample
101. Psychometric properties of the CAMCOG and its efficacy in the diagnosis of dementia
102. Characteristics of elderly who developed Alzheimer's disease during the next two years- a neuropsychological study using CAMCOG
103. A neuropsychological instrument addicting to the description of patients with suspected cortical dementia: The Milan Overall Dementia Assessment
104. The Milan Overall Dementia Assessment and the Mini-Mental State Examination compared: An epidemiological investigation of dementia
105. A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): Development and cross-validation
106. Comparison of clinical state, retrospective informant interview and the neuropathologic diagnosis of Alzheimer's disease
107. Further data on the validity of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE)
108. Cognitive impairment in medical inpatients. I: Screening for dementia - Is history better than mental state?
109. Can an informant questionnaire be used to predict the development of dementia in medical inpatients?
110. Delirium in hospitalized older patients: Recognition and risk factors
111. Development of the nursing home Resident Assessment Instrument in the USA
112. Frontotemporal lobar degeneration: A consensus on clinical diagnostic criteria
113. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop